Association Between Human Papilloma Virus Infection and Malignant Sinonasal Inverted Papilloma

Ronghua Ding1, Qiaorong Sun2, Yong Wang1

  • 1Department of Otorhinolaryngology, Taizhou Second People's Hospital of Jiangsu Province, Taizhou, China.

The Laryngoscope
|October 28, 2020
PubMed
Abstract

Insights

Human papillomavirus (HPV) types 16, 18, and their combinations significantly increase the risk of malignant sinonasal inverted papilloma (SNIP). However, HPV types 6 and 11 do not show a significant association with malignant SNIP development.

Area of Science:

  • Otolaryngology
  • Oncology
  • Virology

Background:

  • Sinonasal inverted papilloma (SNIP) is a benign tumor with a potential for malignant transformation.
  • Human papillomavirus (HPV) infection is implicated in the pathogenesis of various head and neck cancers.
  • The specific role of different HPV types in the malignant progression of SNIP requires further clarification.

Purpose of the Study:

  • To systematically review and meta-analyze the association between specific HPV types and the risk of malignant transformation in SNIP.
  • To quantify the risk of malignant SNIP based on HPV infection status.

Main Methods:

  • A systematic literature search was conducted across PubMed, EmBase, and Web of Science databases.
  • Molecular epidemiological studies reporting HPV types and malignant SNIP risk were included.
  • Quantitative meta-analysis was performed to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs).

Main Results:

  • Twenty-six studies comprising 900 SNIP patients were analyzed.
  • HPV types 16, 18, HPV 11/16, and HPV 16/18 infections were significantly associated with an increased risk of malignant SNIP (ORs ranging from 7.95 to 24.34).
  • HPV types 6, 11, and HPV 6/11 infections did not demonstrate a statistically significant association with malignant SNIP risk.

Conclusions:

  • HPV types 16 and 18 are key oncogenic drivers associated with malignant transformation of SNIP.
  • Patients with SNIP infected by HPV types 16, 18, 11/16, or 16/18 face a substantially elevated risk of developing malignant disease.
  • Further research may focus on HPV-targeted therapies for SNIP management.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K